Enhanced risk probabilities using biomolecule estimations
    3.
    发明授权
    Enhanced risk probabilities using biomolecule estimations 有权
    使用生物分子估计增强风险概率

    公开(公告)号:US08756020B2

    公开(公告)日:2014-06-17

    申请号:US13274309

    申请日:2011-10-15

    IPC分类号: G01N33/50

    CPC分类号: G06F19/18

    摘要: The present invention provides processes for determining more accurate risk probabilities for medical conditions. The risk probabilities of the presence or absence of a medical condition are calculated using frequency data from selected biomolecules and biomolecule source contribution of at least one source in a mixed sample.

    摘要翻译: 本发明提供了用于确定医疗状况的更准确的风险概率的方法。 使用来自所选生物分子的频率数据和混合样品中至少一种来源的生物分子来源贡献来计算存在或不存在医学状况的风险概率。

    RISK CALCULATION FOR EVALUATION OF FETAL ANEUPLOIDY
    6.
    发明申请
    RISK CALCULATION FOR EVALUATION OF FETAL ANEUPLOIDY 审中-公开
    风险计算用于评估子宫颈神经元

    公开(公告)号:US20120190557A1

    公开(公告)日:2012-07-26

    申请号:US13316154

    申请日:2011-12-09

    IPC分类号: C12Q1/68 C40B20/00

    CPC分类号: G16B20/00

    摘要: The present invention provides processes for determining accurate risk probabilities for chromosome dosage abnormalities. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.

    摘要翻译: 本发明提供了确定染色体剂量异常的准确风险概率的方法。 具体地,本发明通过染色体选择性测序和母体样品的非宿主部分数据分析来提供对基因组变异的非侵入性评估。

    ASSAY SYSTEMS FOR DETERMINATION OF FETAL COPY NUMBER VARIATION
    8.
    发明申请
    ASSAY SYSTEMS FOR DETERMINATION OF FETAL COPY NUMBER VARIATION 审中-公开
    用于确定复制次数变化的测定系统

    公开(公告)号:US20120191367A1

    公开(公告)日:2012-07-26

    申请号:US13426157

    申请日:2012-03-21

    IPC分类号: G06F19/00

    CPC分类号: G16B20/00

    摘要: The present invention provides processes for determining accurate risk probabilities for chromosome dosage abnormalities. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.

    摘要翻译: 本发明提供了确定染色体剂量异常的准确风险概率的方法。 具体地,本发明通过染色体选择性测序和母体样品的非宿主部分数据分析来提供对基因组变异的非侵入性评估。